Mitra Biotech Garners $27,400,000 Series B Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2dfb1810-2c32-4fa7-9731-b9de6fbb4b99 - Date
8/31/2016 - Company Name
Mitra Biotech - Mailing Address
12 Gill St. Woburn, MA 01801 USA - Company Description
Mitra Biotech is the global leader in therapy selection in oncology. Mitra is led by an accomplished team of diagnostic and drug development professionals and is backed by world leading venture groups with long term commitment to Mitra’s vision in personalized cancer care. - Website
http://www.mitrabiotech.com - Transaction Type
Venture Equity - Transaction Amount
$27,400,000 - Transaction Round
Series B - Proceeds Purposes
Mitra will use the funds to expand the availability of its CANScript service, which predicts personalised responses to cancer treatments. - M&A Terms
- Venture Investor
Sequoia India - Venture Investor
Sands Capital Management - Venture Investor
RA Capital - Venture Investor
Accel Partners - Venture Investor
Tata Industries
